Sanofi SA (SNY)
47.98
+0.20
(+0.42%)
USD |
NASDAQ |
Nov 21, 16:00
47.86
-0.12
(-0.25%)
Pre-Market: 09:16
Sanofi Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 139.08B |
| December 31, 2023 | 139.79B |
| June 30, 2023 | 136.23B |
| December 31, 2022 | 135.90B |
| June 30, 2022 | 127.26B |
| December 31, 2021 | 136.14B |
| June 30, 2021 | 133.67B |
| June 30, 2020 | 130.26B |
| December 31, 2019 | 126.16B |
| June 30, 2019 | 125.69B |
| December 31, 2018 | 127.44B |
| June 30, 2018 | 130.40B |
| December 31, 2017 | 119.75B |
| December 31, 2016 | 110.66B |
| December 31, 2015 | 111.87B |
| June 30, 2015 | 109.83B |
| December 31, 2014 | 118.43B |
| June 30, 2014 | 123.77B |
| December 31, 2013 | 132.64B |
| June 30, 2013 | 126.40B |
| December 31, 2012 | 132.78B |
| Date | Value |
|---|---|
| June 30, 2012 | 126.58B |
| December 31, 2011 | 130.40B |
| June 30, 2011 | 144.18B |
| December 31, 2010 | 113.40B |
| June 30, 2010 | 105.46B |
| December 31, 2009 | 114.76B |
| June 30, 2009 | 107.75B |
| December 31, 2008 | 100.59B |
| June 30, 2008 | 106.40B |
| December 31, 2007 | 104.97B |
| June 30, 2007 | 101.59B |
| December 31, 2006 | 102.59B |
| June 30, 2006 | 104.35B |
| December 31, 2005 | 102.86B |
| June 30, 2005 | 107.71B |
| December 31, 2004 | 115.75B |
| June 30, 2004 | 12.85B |
| December 31, 2003 | 12.25B |
| June 30, 2003 | 10.16B |
| December 31, 2002 | 9.932B |
| June 30, 2002 | 9.350B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
126.16B
Minimum
Dec 2019
139.79B
Maximum
Dec 2023
133.83B
Average
135.90B
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 104.92B |
| GSK PLC | 77.68B |
| Eli Lilly and Co | 75.61B |
| Novavax Inc | 1.712B |
| Regeneron Pharmaceuticals Inc | 37.44B |
Total Assets (Quarterly) Related Metrics
| Net Debt Paydown Yield | 2.85% |